Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImmunityBio Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.08 | -$0.06 | -$0.07 |
| Q2 2026 | 2 | -$0.09 | -$0.07 | -$0.08 |
| Q3 2026 | 2 | -$0.08 | -$0.07 | -$0.08 |
| Q4 2026 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q1 2027 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q2 2027 | 1 | -$0.03 | -$0.02 | -$0.02 |
| Q3 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q1 2028 | 1 | $0.10 | $0.12 | $0.11 |
| Q2 2028 | 1 | $0.12 | $0.15 | $0.14 |
| Q3 2028 | 1 | $0.12 | $0.15 | $0.13 |
| Q4 2028 | 1 | $0.12 | $0.15 | $0.13 |
ImmunityBio Inc Earnings Date And Information
ImmunityBio Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.62 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0.54. The company had revenue of 44.21 M for the quarter and had revenue of 113.29 M for the year. ImmunityBio Inc has generated $0 earnings per share over the last year ($-0.38 diluted earnings per share) and currently has a price-to-earnings ratio of -9.79. ImmunityBio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
ImmunityBio Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$0.08 | -$0.62 | -0.54 | $43.07 M | $44.21 M |
| 02/23/2026 | Q4 2025 | -$0.08 | -$0.06 | 0.02 | $38.36 M | $38.29 M |
| 11/04/2025 | Q3 2025 | N/A | -$0.07 | N/A | $31.88 M | $32.06 M |
| 08/05/2025 | Q2 2025 | -$0.10 | -$0.10 | 0 | $23.15 M | $26.43 M |
| 05/12/2025 | Q1 2025 | -$0.12 | -$0.15 | -0.03 | $15.98 M | $16.52 M |
| 03/03/2025 | Q4 2024 | -$0.26 | -$0.08 | 0.18 | $9.63 M | $7.55 M |
| 11/12/2024 | Q3 2024 | -$0.18 | -$0.12 | 0.06 | $2.93 M | $6.11 M |
| 08/12/2024 | Q2 2024 | -$0.17 | -$0.20 | -0.03 | $14.71 M | $1.05 M |
| 05/09/2024 | Q1 2024 | -$0.16 | -$0.20 | -0.04 | $62.50 K | $40.00 K |
| 03/19/2024 | Q4 2023 | -$0.18 | -$0.40 | -0.22 | N/A | $139.00 K |
| 11/08/2023 | Q3 2023 | N/A | -$0.19 | N/A | N/A | $82.00 K |
| 08/08/2023 | Q2 2023 | -$0.26 | -$0.32 | -0.06 | N/A | $41.00 K |
| 05/11/2023 | Q1 2023 | -$0.27 | -$0.35 | -0.08 | N/A | $360.00 K |
| 03/01/2023 | Q4 2022 | -$0.22 | -$0.27 | -0.05 | N/A | $73.00 K |
| 11/08/2022 | Q3 2022 | -$0.23 | -$0.28 | -0.05 | N/A | $118.00 K |
| 08/08/2022 | Q2 2022 | -$0.24 | -$0.24 | 0 | N/A | $35.00 K |
| 05/10/2022 | Q1 2022 | -$0.22 | -$0.26 | -0.04 | N/A | $14.00 K |
| 03/01/2022 | Q4 2021 | -$0.21 | -$0.23 | -0.02 | N/A | $390.00 K |
| 11/12/2021 | Q3 2021 | -$0.20 | -$0.22 | -0.02 | N/A | $66.00 K |
| 08/12/2021 | Q2 2021 | -$0.12 | -$0.23 | -0.11 | N/A | $339.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ImmunityBio Inc Earnings: FAQ's
The conference call for ImmunityBio Inc's latest earnings report can be listened to online.
The conference call transcript for ImmunityBio Inc's latest earnings report can be read online.
ImmunityBio Inc (:IBRX) has a recorded annual revenue of $113.29 M.
ImmunityBio Inc (:IBRX) has a recorded net income of $-351,398,000.ImmunityBio Inc has generated $-0.38 earnings per share over the last four quarters.
ImmunityBio Inc (:IBRX) has a price-to-earnings ratio of -9.79 and price/earnings-to-growth ratio is 0.07.